Potassium Carbonate → Pyrimidin-4-yl-5,6,8,9-tetrahydro-7-oxa-1,4a-diaza-benzocyclohepten-4-one

HRID 1886963Notes

Reaction equation

HRID 1886963 reaction equation
Cl.[O:2]1[CH2:8][CH2:7][C:6]([NH2:9])=[N:5][CH2:4][CH2:3]1.C(=O)([O-])[O-].[K+].[K+].[N:16]1[CH:21]=[CH:20][C:19]([C:22](=O)[CH2:23][C:24](OCC)=[O:25])=[N:18][CH:17]=1>C(O)C>[N:16]1[CH:21]=[CH:20][C:19]([C:22]2[N:9]=[C:6]3[CH2:7][CH2:8][O:2][CH2:3][CH2:4][N:5]3[C:24](=[O:25])[CH:23]=2)=[N:18][CH:17]=1

Participants

5

Procedure

To a suspension of 25.00 g (165.99 mmol) of 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine monohydrochloride (synthesis as described in WO97/16430 and Bioorganic & Medicinal Chemistry Letters (2004), 14(23), 5907-5911) in 550 mL of ethanol was added 25.23 g (182.59 mmol) of potassium carbonate. The reaction mixture was stirred at room temperature for 10 min, 35.45 g (182.59 mmol) of ethyl 3-(4-pyrimidinyl)-3-oxopropionate was added and the resulting mixture was stirred under reflux for 4 hours. The cooled solution was evaporated to remove solvent. The mixture was dissolved with water and diethyl ether. After stirring, the resulting solid was filtered, washed with water and diethyl ether to afford 21.7 g (53%) of the desired compound as a powder.

Workup

  1. customsynthesis
  2. stirringthe resulting mixture was stirred
  3. temperatureunder reflux for 4 hours
  4. customThe cooled solution was evaporated
  5. customto remove solvent
  6. dissolutionThe mixture was dissolved with water and diethyl ether
  7. stirringAfter stirring
  8. filtrationthe resulting solid was filtered
  9. washwashed with water and diethyl ether

Sources & evidence

ORD record
ord-34efcbcdf2a04708aed7be3836360bdb
Source dataset
uspto-grants-2013_08
Patent number
US08501728B2

Reaction notes

Loading…